Molecular docking and dynamics simulations studies of OmpATb identifies four potential novel natural product-derived anti-Mycobacterium tuberculosis compounds. (July 2020)

• Record Type: Journal Article
• Authors: Kwofie, Samuel K.; Adobor, Courage; Quansah, Erasmus; Bentil, Joana; Ampadu, Michael; Miller, Whelton A.; Wilson, Michael D.
• Is Part Of: Computers in biology and medicine. Volume 122(2020)
• Publication Date: 2020-07
• Subjects: Mycobacterium tuberculosis OmpATb -- Natural products -- Virtual screening -- Molecular docking -- Molecular dynamics -- MM-PBSA -- Antitubercular compounds -- Induced-fit docking; Medicine -- Data processing -- Periodicals; Biology -- Data processing -- Periodicals; 610.285
• DOI: 10.1016/j.compbiomed.2020.103811
• Languages: English
• ISSNs: 0010-4825

Abstract

Abstract: The outer membrane protein A (OmpATb) of Mycobacterium tuberculosis is a virulence factor that neutralizes the host pH to impede the uptake of hydrophilic antitubercular drugs. Identifying natural compounds with the potential to inhibit OmpATb could allow circumvention of the porin-like activities of OmpATb. Four potential leads comprising ZINC000003958185, ZINC000000157405, ZINC000000001392 and ZINC000034268676 were obtained by virtual screening of 6394 diverse natural products. Characterization of the binding interactions of the potential leads with OmpATb revealed nine critical residues comprising ARG86, LEU110, LEU113, LEU114, ALA115, PHE142, SER145, VAL146, and PHE151. Molecular dynamics simulations also revealed very stable protein-lead complexes. Most residues contributed lower binding energies to the overall molecular mechanics Poisson–Boltzmann surface area (MM-PBSA) binding free energies of the interactions between the molecules and OmpATb protein. Induced Fit Docking (IFD) of the compounds regenerated poses of the molecular docking using AutoDock Vina. These molecules could be starting templates for designing inhibitors to bypass the pore mediating activities of OmpATb. Based on structural similarity, ZINC000034268676 was suggested as a potential scaffold for designing efflux pump inhibitors of the gate mediating activities of OmpATb and may enhance the uptake of hydrophilic drugs to reduce the duration time of tuberculosis treatment. Furthermore, structurally similar compounds available in the DrugBank database with a similarity threshold of 0.7 have been reported to exhibit antitubercular and anti-mycobacterial activities. These biomolecules can be further characterized experimentally to corroborate their antitubercular activity. Also, the skeletons of the molecules can be adopted as sub-structures for the design of future anti-mycobacterial drugs. Highlights: New insights into the binding mechanisms of OmpATb. Four scaffolds for antitubercular drug design. A scaffold for designing efflux pump inhibitors against OmpATb. Four potential novel anti-tubercular molecules for in vitro activity testing.